Viewing Study NCT06398457

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 6:57 PM

Ignite Modification Date: 2026-01-03 @ 6:42 AM

Study NCT ID: NCT06398457

Status: RECRUITING

Last Update Posted: 2025-09-26

First Post: 2024-05-01

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module